The markets advanced during the midday with the Dow soaring 158 points to 17,133 as the nation's trade deficit narrowed. Nasdaq added 5 points to 4,554.

On the upside

The Center for Medicare & Medicaid Services granted transitional pass-through status to Omeros (Nasdaq: OMER) for its Omidria.

Abiomed (Nasdaq: ABMD) reported sharply higher second quarter earnings that more than tripled to top analyst estimates. 

Calix (NYSE: CALX) fell to a loss for the third quarter but the results were better than expected.

On the downside

Yamana Gold (NYSE: AUY) fell to a greater than expected loss for the third quarter.

Accuray (Nasdaq: ARAY) widened first quarter losses more than expected.

Parexel International (Nasdaq: PRXL) reported higher first quarter earnings but revenue missed expectations prompting a downgrade.

In the broad market, advancing issues outpaced decliners by a margin of more than 7 to 5 on the NYSE and by more than 10 to 9 on Nasdaq. The broader S&P 500 gained 7 points to 1989. Bitcoin slipped $2 to $334.

Mixed open over GDP

|
The markets opened mixed with the Dow climbing 92 points to 17,066 while Nasdaq lost 16 points to 4,532 as the nation's gross domestic product expanded at a 3.5% rate in the third quarter. The pace was lower than the 4.6% growth rate in the second quarter.

On the upside

Alcatel-Lucent (NYSE: ALU) narrowed losses for the third quarter.

The Patent and Trademark Office granted two patents to Clean Diesel Technologies (Nasdaq: CDTI) for the company's Spinel(TM) clean emissions exhaust technology that would be significantly cheaper than current technology. 

Lakeland Industries (Nasdaq: LAKE) increased production of its ChemMAX and MicroMAX protective suits and will continue to add production capacity.

On the downside

Glu Mobile (Nasdaq: GLUU) swung to a profit for the third quarter but the company forecast current quarter results below estimates.

Ceragon Networks (Nasdaq: CRNT) reported a greater than expected loss for the third quarter.

Pacira Pharmaceuticals (Nasdaq: PCRX) reported a loss for the third quarter.

In the broad market, declining issues outpaced advancers by a margin of more than 9 to 7 on both the NYSE and on Nasdaq. The broader S&P 500 eased a point to 1980. Bitcoin slipped $2 to $334.

Lower close as Fed ends QE

|
The markets closed lower with the Dow losing 31 points to 16,974 after the Federal Reserve ended its bond buying program. Nasdaq fell 15 points to 4,549.

On the upside

Radcom (Nasdaq: RDCM) reversed year ago losses to post a profit for the third quarter as revenue soared.

USANA Health Sciences (NYSE: USNA) reported higher third quarter earnings and revenue. 

Amedisys (Nasdaq: AMED) swung to a greater than expected profit for the third quarter prompting an upgrade.

On the downside

Barrett Business Services (Nasdaq: BBSI) fell to a loss for the third quarter.

Facebook (Nasdaq: FB) reported sharply higher third quarter earnings and revenue but the company forecast disappointing fourth quarter results and warned of higher expenses in 2015.

Compass Point downgraded AmTrust Financial Services (Nasdaq: AFSI) from a Buy rating to a Neutral rating.

In the broad market, declining issues outpaced advancers by a margin of more than 9 to 7 on the NYSE and by more than 10 to 9 on Nasdaq. The broader S&P 500 slipped 2 points to 1982. Bitcoin held steady at $336.

Mixed earnings weighs down markets

|
Mixed corporate earnings news weighed the markets down during the midday with the Dow slipping 9 points to 16,995. Nasdaq fell 23 points to 4,540.

On the upside

Shares of Shell Midstream Partners (NYSE: SHLX) surged on its first trading day.

ACCO Brands (NYSE: ACCO) reported higher third quarter earnings that surpassed analyst expectations prompting the company to lift its full year guidance. 

Third quarter earnings fell for MCG Capital (Nasdaq: MCGC) but the company announced plans to repurchase up to $75 million of its common stock.

On the downside

Applied Micro Circuits (Nasdaq: AMCC) narrowed losses for the second quarter but the results fell short of analyst expectations.

An Orbital Sciences (NYSE: ORB) Antares rocket exploded after lifting off last night in Virginia.

Wabash National (NYSE: WNC) reported higher third quarter earnings and revenue but the results missed estimates.

In the broad market, declining issues outpaced advancers by a margin of 10 to 9 on the NYSE and by 3 to 2 on Nasdaq. The broader S&P 500 eased a point to 1983. Bitcoin lost 13 points to $338.

Mixed open ahead of Fed statement

|
The markets opened mixed with the Dow gaining 37 points to 17,042 while Nasdaq lost 15 points to 4,548 as investors awaited a statement from the Federal Reserve.

On the upside

Fiat Chrysler Automotive (NYSE: FCAU) will spin off Ferrari into a separate publicly traded company and will issue a convertible bond for $2.5 billion.

Goodyear Tire & Rubber (Nasdaq: GT) reported lower third quarter earnings but the results were better than expected. 

Newfield Exploration (NYSE: NFX) reported sharply higher third quarter earnings as revenue climbed.

On the downside

American Realty Capital Properties (Nasdaq: ARCP) overstated its adjusted funds from operations in its financial reports from March 31, 2014 and June 30, 2014.

InvenSense (NYSE: INVN) fell to an unexpected loss for the second quarter even as revenue rose.

Xoom (Nasdaq: XOOM) reported sharply lower third quarter earnings even as revenue rose.

In the broad market, advancing issues outpaced decliners by a margin of more than 5 to 3 on the NYSE and by nearly 5 to 4 on Nasdaq. The broader S&P 500 rose 3 points to 1988. Bitcoin lost 12 points to $339.

Upbeat data sends markets soaring

|
Upbeat earnings and strong gains in consumer confidence sent the markets soaring to a sharply higher close with the Dow surging 187 points to 17,005. Nasdaq leaped 78 points to 4,564.

On the upside

Apple (Nasdaq: AAPL) selected Aerohive Networks (NYSE: HIVE) to provide networking solutions for the ConnectED Initiative.

Medicines Company (Nasdaq: MDCO) won its patent infringement suit against Mylan. 

Tornier (Nasdaq: TRNX) will merge with Wright Medical Group (Nasdaq: WMGI) in an all stock deal valued at approximately $3.3 billion.

On the downside

Pioneer Energy Services (NYSE: PES) reversed year ago losses to post a profit for the third quarter but the results fell short of analyst expectations.

Investors locked in profits on Cyber-Ark Software (Nasdaq: CYBR).

Medidata Solutions (Nasdaq: MDSO) reported sharply lower third quarter earnings even as revenue rose and lowered its full year outlook.

In the broad market, advancing issues outpaced decliners by a margin of more than 5 to 1 on the NYSE and by more than 4 to 1 on Nasdaq. The broader S&P 500 soared 23 points to 1985. Bitcoin added 2 points to $353.
A strong gain in consumer confidence boosted the markets during the midday with the Dow climbing 78 points to 16,896. Nasdaq surged 50 points to 4,536.

On the upside

Cliffs Natural Resources (NYSE: CLF) fell to a loss for the third quarter as revenue dropped but the results were better than expected.

Receptos (Nasdaq: RCPT) reported positive results for a Phase 2 trial of its ulcerative colitis treatment RPC1063. 

VASCO Data Security International (Nasdaq: VDSI) reported sharply higher earnings for the third quarter that more than tripled as revenue climbed.

On the downside

Amkor Technology (Nasdaq: AMKR) reported higher third quarter earnings and revenue but the results fell short of analyst expectations.

NQ Mobile (NYSE: NQ) rejected an offer from Bison Capital to take the company private.

Kohl's (NYSE: KSS) warned of lower comparable sales in the third quarter.

In the broad market, advancing issues outpaced decliners by a margin of more than 3 to 1 on the NYSE and by nearly 7 to 2 on Nasdaq. The broader S&P 500 gained 11 points to 1973. Bitcoin added a point to $352.
Upbeat earnings lifted the markets to a higher open with the Dow rising 38 points to 16,856. Nasdaq soared 40 points to 4,526.

On the upside

Second quarter earnings fell for Integrated Device Technology (Nasdaq: IDTI) but the results were better than expected.

Madison Square Garden (Nasdaq: MSG) will explore separating the company into two businesses. 

China granted Ascent Solar Technologies (Nasdaq: ASTI) the Business License and the Certificate of Approval for Establishment of Enterprises with Foreign Investment required to begin operations at its China Joint Venture manufacturing facility.

On the downside

Twitter (NYSE: TWTR) widened third quarter losses as user growth slowed prompting downgrades.

Sanofi (NYSE: SNY) reported higher third quarter earnings and revenue but the company warned of challenges to its diabetes sales through 2015.

Coach (NYSE: COH) reported lower first quarter earnings and revenue.

In the broad market, advancing issues outpaced decliners by a margin of nearly 4 to 1 on the NYSE and by 3 to 1 on Nasdaq. The broader S&P 500 rose 7 points to 1969. Bitcoin added 2 points to $353.
The markets closed modestly higher with the Dow rising 12 points to 16,817 despite disappointing economic data as investors focused on upbeat earnings. Nasdaq added 2 points to 4,485.

On the upside

The underwriters of Vitae Pharmaceuticals' (Nasdaq: VTAE) initial public offering exercised their option to purchase over 1 million shares of common stock at the IPO price of $8 per share.

Shares of Cyber-Ark Software (Nasdaq: CYBR) continued climbing. 

Trex (NYSE: TREX) reversed year ago losses to post a profit for the third quarter as revenue climbed.

On the downside

Shares of Durect (Nasdaq: DRRX) plunged after Pfizer (NYSE: PFE) ended its partnership with Pain Therapeutics (Nasdaq: PTIE) to develop Remoxy. Pain had licensed the right to develop Remoxy from Durect.

GoPro (Nasdaq: GPRO) stock extended its losses.

Investors locked in profits on SodaStream International (Nasdaq: SODA)

In the broad market, declining issues outpaced advancers by a margin of more than 5 to 4 on the NYSE and by more than 10 to 9 on Nasdaq. The broader S&P 500 slipped 2 points to 1961. Bitcoin slipped 2 points to $350.
Service sector expansion slowed in October to weigh the markets down during the midday with the Dow slipping 12 points to 16,792. Nasdaq lost 5 points to 4,478.

On the upside

Shares of Regulus Therapeutics (Nasdaq: RGLS) continued soaring.

Bargain hunters snapped up shares of Layne Christensen (Nasdaq: LAYN). 

Chembio Diagnostics (Nasdaq: CEMI) partnered with Integrated BioTherapeutics to develop point-of-care diagnostic tests for Ebola and febrile illness.

On the downside

Akebia (Nasdaq: AKBA) reported positive results from a Phase 2b trial of non-dialysis patients with anemia related chronic kidney disease treatment AKB-6548 but a high rate of serious adverse event reports raised concerns.

The re-election of Brazilian President Dilma Rousseff weighed down shares of Centrais (NYSE: EBR) and Gafisa (NYSE: GFA).

Tenneco (NYSE: TEN) reported higher third quarter earnings that topped analyst estimates but the stock price fell.

In the broad market, declining issues outpaced advancers by a margin of more than 7 to 5 on the NYSE and by a 9 to 7 on Nasdaq. The broader S&P 500 slipped 4 points to 1959. Bitcoin added a point to $354.
Powered by Movable Type 5.12